106070-58-0 Usage
Uses
Used in Pharmaceutical Industry:
2,5-DIAMINO-3-PICOLINE is used as an intermediate in the synthesis of various pharmaceutical compounds due to its ability to form heterocyclic structures, which are common in many drug molecules.
Used in Agrochemical Industry:
In the agrochemical sector, 2,5-DIAMINO-3-PICOLINE is used as a precursor in the production of certain pesticides and other agrochemicals, contributing to the development of effective crop protection agents.
Used in Dye Industry:
2,5-DIAMINO-3-PICOLINE is employed as a key component in the synthesis of dyes, particularly those used in various industrial applications, due to its ability to form colored compounds.
Used in Organic Synthesis:
As a versatile building block, 2,5-DIAMINO-3-PICOLINE is used in organic synthesis for the creation of a wide range of chemical compounds, including heterocyclic compounds, which have diverse applications across different industries.
It is crucial to handle 2,5-DIAMINO-3-PICOLINE with care, as it can be harmful if ingested, inhaled, or comes into contact with the skin. Proper safety measures should be implemented when working with this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 106070-58-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,0,7 and 0 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 106070-58:
(8*1)+(7*0)+(6*6)+(5*0)+(4*7)+(3*0)+(2*5)+(1*8)=90
90 % 10 = 0
So 106070-58-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H9N3/c1-4-2-5(7)3-9-6(4)8/h2-3H,7H2,1H3,(H2,8,9)/p+1
106070-58-0Relevant articles and documents
N- (6-AMINOPYRIDIN-3-YL) -3- (SULFONAMIDO) BENZAMIDE DERIVATIVES AS B-RAF INHIBITORS FOR THE TREATMENT OF CANCER
-
Page/Page column 55, (2009/10/22)
Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.